Generate Biomedicines is a Biotech company. It has raised $750M in total funding. Latest round: IPO.
Generate Biomedicines funding overview
Generate Biomedicines is a Biotech company. Generate Biomedicines has raised $750M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in January 2026. The round record for Generate Biomedicines runs through 2026; nothing later has been disclosed.
Generate Biomedicines at a glance
Total raised
$750M
Latest round
IPO
Latest round date
January 2026
Industry
Biotech
Frequently asked about Generate Biomedicines funding
How much has Generate Biomedicines raised?
Generate Biomedicines has raised $750M in total disclosed funding across the rounds on record.
Who has invested in Generate Biomedicines?
No investors are named on the public record for Generate Biomedicines yet.
What was the latest Generate Biomedicines funding round?
The most recent disclosed round is an IPO, announced in January 2026.
Where is Generate Biomedicines based?
No headquarters location is disclosed for Generate Biomedicines.
What sector does Generate Biomedicines operate in?
Generate Biomedicines is tracked under Biotech, with $750M in disclosed funding.
When did Generate Biomedicines last raise?
The last disclosed Generate Biomedicines round closed in January 2026 at IPO.
We update the Generate Biomedicines record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies and their backers are listed below.
